Severe Disease Activity and Cytomegalovirus Colitis Are Predictive of a Nonresponse to Infliximab in Patients with Ulcerative Colitis

@article{Park2013SevereDA,
  title={Severe Disease Activity and Cytomegalovirus Colitis Are Predictive of a Nonresponse to Infliximab in Patients with Ulcerative Colitis},
  author={Sang Hyoung Park and Suk Kyun Yang and Seung-Mo Hong and Soo-Kyung Park and Jong Wook Kim and Hyo Jeong Lee and Dong-Hoon Yang and Kee Wook Jung and Kyung-Jo Kim and Byong Duk Ye and Jeong-Sik Byeon and S J Myung and Jin-Ho Kim},
  journal={Digestive Diseases and Sciences},
  year={2013},
  volume={58},
  pages={3592-3599}
}
The role of infliximab in the treatment of patients with ulcerative colitis (UC) in Asia is still unclear. The aim of this study was to evaluate the clinical outcomes of infliximab therapy in Korean UC patients, including efficacy and predictors of response. Patients who received infliximab induction therapy for moderate to severe UC at Asan Medical Center were retrospectively analyzed. The demographic characteristics of these patients and their clinical outcomes following infliximab therapy… CONTINUE READING
Highly Cited
This paper has 26 citations. REVIEW CITATIONS

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

Can We Predict the Efficacy of Anti-TNF-α Agents?

International journal of molecular sciences • 2017
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 37 references

The prevalence and efficacy of ganciclovir on steroid-refractory ulcerative colitis with cytomegalovirus infection: a prospective multicenter study

YS Kim, YH Kim, JS Kim
J Clin Gastroenterol • 2012
View 1 Excerpt